Kedrab 300 unit/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FTWN8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,990
Award facts
- Contract value 100% obligated
- $3,990.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,990.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. The delivery order calls for 300 units of Kedrab in 2 milliliter vials and carries a firm fixed-price contract structure with an ultimate completion date of October 16, 2025. Performance will take place in Conshohocken, Pennsylvania. This award was made without any set-aside designation, allowing the vendor to compete directly in the open federal marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion blanket purchasing agreement valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide, including prescription medications, biologics, over-the-counter products, and specialty pharmaceuticals. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering essential medical products to Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FTWN8?
SPE2DB25FTWN8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWN8 worth?
The government has obligated $3,990 on SPE2DB25FTWN8.
Is contract SPE2DB25FTWN8 an order under another contract?
Yes. SPE2DB25FTWN8 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWN8 competed?
The extent of competition for SPE2DB25FTWN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award